 |
|
New guidelines issued for diagnosis and management of venous thromboembolism
January 30, 2007Recommendations are a joint effort of the American Academy of Family Physicians and the American College of Physicians
LEAWOOD, Kan. - The American Academy of Family Physicians (AAFP) and American College of Physicians (ACP) today released new clinical practice guidelines for the diagnosis and management of venous thromboembolism (VTE).
Key elements of the diagnosis guideline include the use of clinical prediction rules to establish pretest probability of deep vein thrombosis or pulmonary embolism in a patient before further testing and the utility of various diagnostic tools such as D-dimer and ultrasonography. The management guideline supports the use of low-molecular weight heparin for patients with deep vein thrombosis in the outpatient setting when appropriate support services are in place. Each guideline contains several recommendations to aid in the diagnosis and treatment of lower extremity deep venous thrombosis and pulmonary embolism.
A thromboembolism occurs when a blood clot, formed at one point in the circulatory system, detaches and obstructs circulation at another point. A pulmonary embolism occurs when such a clot, usually originating in the veins of the leg, obstructs the pulmonary artery or one of its branches. A large embolus may result in acute heart failure or sudden death. More than 200,000 deaths each year are associated with VTE in the United States.
The Annals of Family Medicine and Annals of Internal Medicine have joined in publishing the new guidelines. Both guidelines and an evidence review for the diagnosis guideline are published in this issue of Annals of Family Medicine. The management guideline is being published at www.annals.org on Monday, Jan. 29, at 6 p.m. EST. The management guideline and companion evidence review will be published in the Feb. 6, 2007, issue of Annals of Internal Medicine.
The new diagnosis guideline targets primary care physicians who are most likely to have frontline contact with patients who have not yet been diagnosed. The guideline aims to present evidence-based recommendations for diagnosis of lower extremity DVT and pulmonary embolism.
"These new guidelines represent a collaborative effort between family medicine and internal medicine," said Rick Kellerman, M.D., AAFP president. "We are pleased to collaborate with the American College of Physicians on this endeavor to provide physicians with the tools they need to prevent mortality and morbidity associated with venous thromboembolism."
Incidence rates for VTE are higher in men, African-Americans, and increase substantially with age. Treating VTE at an early stage can avoid complications such as pulmonary embolism or recurrent DVT.
"ACP has been producing evidence-based clinical practice guidelines since 1981 to help physicians provide the best health care possible, based on the best available current evidence," said Amir Qaseem, MD, PhD, MHA, senior medical associate in the Clinical Programs and Quality of Care department of the Medical Education and Publishing Division at the American College of Physicians. "These guidelines provide information on the utility of various diagnostic tools and compare the efficacy and safety of various pharmacologic agents used for treatment of VTE."
American Academy of Family Physicians
A thromboembolism occurs when a blood clot, formed at one point in the circulatory system, detaches and obstructs circulation at another point. A pulmonary embolism occurs when such a clot, usually originating in the veins of the leg, obstructs the pulmonary artery or one of its branches. A large embolus may result in acute heart failure or sudden death. More than 200,000 deaths each year are associated with VTE in the United States.
The Annals of Family Medicine and Annals of Internal Medicine have joined in publishing the new guidelines. Both guidelines and an evidence review for the diagnosis guideline are published in this issue of Annals of Family Medicine. The management guideline is being published at www.annals.org on Monday, Jan. 29, at 6 p.m. EST. The management guideline and companion evidence review will be published in the Feb. 6, 2007, issue of Annals of Internal Medicine.
The new diagnosis guideline targets primary care physicians who are most likely to have frontline contact with patients who have not yet been diagnosed. The guideline aims to present evidence-based recommendations for diagnosis of lower extremity DVT and pulmonary embolism.
"These new guidelines represent a collaborative effort between family medicine and internal medicine," said Rick Kellerman, M.D., AAFP president. "We are pleased to collaborate with the American College of Physicians on this endeavor to provide physicians with the tools they need to prevent mortality and morbidity associated with venous thromboembolism."
Incidence rates for VTE are higher in men, African-Americans, and increase substantially with age. Treating VTE at an early stage can avoid complications such as pulmonary embolism or recurrent DVT.
"ACP has been producing evidence-based clinical practice guidelines since 1981 to help physicians provide the best health care possible, based on the best available current evidence," said Amir Qaseem, MD, PhD, MHA, senior medical associate in the Clinical Programs and Quality of Care department of the Medical Education and Publishing Division at the American College of Physicians. "These guidelines provide information on the utility of various diagnostic tools and compare the efficacy and safety of various pharmacologic agents used for treatment of VTE."
American Academy of Family Physicians
Thromboembolism Current Events and Thromboembolism News RSSMenopause-cardiology consensus statement on cardiovascular disease and on HRT
A menopause-cardiology consensus statement has called for direct action to prevent cardiovascular disease (CVD) in menopausal women. The statement also concludes that there is little evidence of increased CVD risk in taking HRT.
Drugs to treat anemia in cancer patients linked to thromboembolism
Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center.
Study of adjuvant endocrine treatment for breast cancer reveals cost of noncompliance
The largest study in the world of treatments for post menopausal, hormone positive breast cancer has shown that patients who continue to take exemestane or tamoxifen do significantly better than patients who start to take one or other drug (or tamoxifen followed exemestane) but then stop.
Elevated level of certain protein in urine linked to increased risk for blood clots
Preliminary research suggests that higher than normal levels of the protein albumin in urine is associated with an increased risk for blood clots in the deep veins of the legs or lungs (venous thromboembolism; VTE), according to a study in the May 6 issue of JAMA.
New study suggests Rx estrogen delivery through the skin may show safety benefits as opposed to oral delivery
Transdermal delivery of estrogen therapy available by prescription "seems not to alter" the risk of venous thromboembolism (VTE), or blood clotting, in postmenopausal patients when compared to oral delivery, a new study suggests.
Study shows optimal dose management of warfarin improves anticoagulation control
Researchers from Boston University School of Medicine (BUSM) have determined the optimal dose-management strategy to derive maximal benefit from warfarin therapy and improve patient outcomes. Results of the study appear online in the December 2008 issue of the Journal of Thrombosis and Haemostasis.
Research highlights new approaches to prevent blood clots
Blood clotting, or coagulation, is an important process that prevents excessive bleeding when a blood vessel is injured.
Women may stop anticoagulants after blood clots
Women may safely discontinue oral anticoagulants (blood thinners) after 6 months of treatment following a first unprovoked venous blood clot (thromboembolism) if they have no or one risk factor.
Maternal deaths following cesarean delivery can be reduced
Maternal death rates have remained constant in the United States for many decades. Are there any improvements in health care that could reduce these rates further?
New blood clot guidelines for pregnant women
New evidence-based guidelines address the prevention and management of thrombosis in key patient populations and reinforce recommendations related to the routine use of preventive therapies.
More Thromboembolism Current Events and Thromboembolism News Articles
 |
Venous Thromboembolism in Advanced Disease: A clinical guide by Simon I R Noble (Editor), Miriam J Johnson (Editor), Agnes Y Y Lee (Editor) There is increasing recognition of the burden of venous thromboembolism (VTE) in patients with advanced incurable disease and the clinical, ethical, and philosophical challenges they may pose. With a growing elderly population and oncological therapies helping patients live longer with malignant disease, VTE is likely to be an ongoing problem. Whilst presentation, diagnosis, and treatment of VTE in general medicine is well established, its management within the palliative care setting is less clear-cut. Clinical presentation is often masked by other palliative symptoms, and symptoms can be consistent with those of other conditions; diagnosis is therefore underappreciated, and the condition can be difficult to manage. Bringing together contributions from international experts... |
 |
Futuro Anti-Embolism Stockings, Large Regular, White, Thigh Length, Closed Toe, 1 Pair by Futuro Code No. 582200. 18mm/Hg Compression. Reduces the danger of thromboembolism. Designed for the recuperating patient. Sizing Chart: Large Regular (No. 582200) - 1. Calf Circumference (Inches): 17-1/2; 2. Length (Inches): 33. An elastomer system in T.E.D. Stockings is specifically designed to speed blood flow by providing graduated compression with the most compression at the ankle and gradually diminishing pressure up the calf. These stockings are manufactured under the most rigid quality control inspections to assure the precise pressure necessary to discourage thrombus formations. |
|
Deadly Blood Clots: The Dangers Of Venous Thromboembolism Directed By: Information Television Network | |
 |
Deadly Blood Clots: The Dangers of Venous Thromboembolism (Home Use) Part of the award winning public television series Healthy Body/Healthy Mind. The dangers of blood clots are well known: they can cause heart attacks, strokes and other potentially fatal conditions. But there's another medical hazard that occurs when the blood clot lives quietly deep in the veins of the legs. And when a part of this blood clot breaks off and travels to the lung the result can be almost instantaneous death. This type of blood clot is called deep vein thrombosis and when it travels to the lungs its called pulmonary embolism. And these are two manifestations of the condition known as venous thromboembolism. In this program we will examine the symptoms and risk factors of venous thromboembolism, see who should be tested for clotting disorders and highlight the latest... |
 |
- White Anti-Embolism Stockings, Below Knee - Large by Futuro INDICATIONS: Reduces the danger of Thromboembolism. Designed for the recuperating patient.18mm/Hg Compression.An elastomer system in T.E.D. stockings is specifically designed to speed blood flow by providing graduated compression with the most compression at the ankle and gradually diminishing pressure up the calf. These stockings are manufactured under the most rigid quality control inspections to assure the precise pressure necessary to discourage thrombus formations. Size: Calf Circumference 15-17.5 inches, Length 14-18 inches. T.E.D Stocking Precautions: Proper sizing and application must be assured. Measure calf circumference at the greatest portion to determine "size". Measure distance from bend of knee to bottom of heal to determine "length". (If possible, measure length in... |
|
Pediatric Thromboembolism and Stroke Protocols by Maureen Andrew (Author), Gabrielle De Veber (Author) In Canada alone there are hundreds of neonates and children at risk for thrombotic complications related to interventions in cardiac and renal disease, treatments for leukemia and lupus, and ischemic stroke. The authors lay a foundation in the principles of hemostasis, congenital prethrombotic disorders, and the epidemiology of venous and arterial thromboembolism. The management protocols embrace heparin, oral anticoagulants, and thrombolytic therapy. | |
 |
Pediatric Thromboembolism and Stroke by Paul T. Monagle (Author) Andrew's Handbook of Pediatric Thromboembolism and Stroke, Third Edition is created as a manual in pocketbook format. This new edition presents guidelines for initiating and monitoring existing and new drug therapies for the treatment of thromboembolic complications in children. |
|
Tarascon Primary Care Pocketbook Card: Thromboembolism by Joseph Esherick (Author) Measuring only 5.5 x 3.25 inches, this quick and handy laminated card tucks neatly into your Tarascon books to provide you with immediate access to the most frequently used tables in your Tarascon Primary Care Pocketbook. Included in this convenient reference card are treatment options for DVT as well as assessment and treatment information for pulmonary embolism. | |
 |
Futuro Anti-Embolism Stockings, Medium Regular, White, Thigh Length, Closed Toe, 1 Pair by Futuro Code No. 553300. 18mm/Hg Compression. Reduces the danger of thromboembolism. Designed for the recuperating patient. Sizing Chart: Medium Regular (No. 553300) - 1. Calf Circumference (Inches): 15; 2. Length (Inches): 33. An elastomer system in T.E.D. Stockings is specifically designed to speed blood flow by providing graduated compression with the most compression at the ankle and gradually diminishing pressure up the calf. These stockings are manufactured under the most rigid quality control inspections to assure the precise pressure necessary to discourage thrombus formations. |
 |
Thrombosis and Thromboembolism (Fundamental and Clinical Cardiology) by Samuel Z. Goldhaber (Editor), Paul M. Ridker (Editor) Harvard Medical School, Boston, MA. Presents a comprehensive update on this field. Covers fundamental and clinical aspects of this broad topic and focuses on arterial and venous disease, ranging from acute coronary syndromes to acute pulmonary embolism. For clinicians and researchers. Expanded-outline format. |
| © 2009 BrightSurf.com |